Mepolizumab shortage status
1 active shortage notice across 1 country.
Last updated 2 Aug 2026 · sourced from official medicines regulators
- Generic name (INN)
- Mepolizumab
- Brand names
- Nucala
- Class
- Auto-created by European Medicines Agency — Medicines Shortages scraper
Where Mepolizumab is in shortage
| Country | Severity | Notices | Since | Est. resolution | Source |
|---|---|---|---|---|---|
| European Union | high | 1 | 28 Jan 2021 | — | EMA |
Why Mepolizumab is in shortage
- causes not stated by the regulator
Frequently asked questions
Is Mepolizumab currently in shortage?
Yes. As of the latest regulator updates, Mepolizumab has 1 active shortage notice across 1 country (European Union). Status is refreshed daily from official regulatory sources.
Why is Mepolizumab in shortage?
Regulators attribute the current Mepolizumab shortages to causes not stated by the regulator. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Mepolizumab shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Get alerted when Mepolizumab status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.